Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
Journal of Korean Medical Science|December 30, 2015
Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate CancerChunri Yan, Ye-Hwan Kim, Ho Won Kang, et al.
Investigative and Clinical Urology|January 10, 2024
COL6A1 expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtypeKyeong Kim, Young Joon Byun, Chuang-Ming Zheng, et al.
Annals of Surgical Oncology|October 29, 2014
Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPHSeok Joong Yun, Chunri Yan, Pildu Jeong, et al.
Journal of Korean Medical Science|November 20, 2018
CDC6 mRNA Expression Is Associated with the Aggressiveness of Prostate CancerYe-Hwan Kim, Young Joon Byun, Won Tae Kim, et al.
International Journal of Molecular Sciences|December 10, 2021
Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer ProgressionXuan-Mei Piao, Chaelin You, Young Joon Byun, et al.
Journal of Korean Medical Science|July 2, 2015
Lower Levels of Human MOB3B Are Associated with Prostate Cancer Susceptibility and Aggressive Clinicopathological CharacteristicsEun-Ah Kim, Ye-Hwan Kim, Ho Won Kang, et al.
The World Journal of Men'S Health|December 28, 2018
Metabolic Syndrome Is an Independent Risk Factor for Acquired Premature EjaculationSeong Uk Jeh, Sol Yoon, Jae Hwi Choi, et al.
Disease Markers|June 16, 2015
Clinical Implications and Prognostic Values of Prostate Cancer Susceptibility Candidate Methylation in Primary Nonmuscle Invasive Bladder CancerYoung-Won Kim, Hyung-Yoon Yoon, Sung Pil Seo, et al.
International Journal of Molecular Sciences|October 26, 2024
Differential Urinary Microbiome and Its Metabolic Footprint in Bladder Cancer Patients Following BCG TreatmentKyungchan Min, Chuang-Ming Zheng, Sujeong Kim, et al.
International Journal of Molecular Sciences|November 26, 2022
Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk GroupsXuan-Mei Piao, Seon-Kyu Kim, Young Joon Byun, et al.
Pageof 15